Eric Coldwell Baird Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
25
Avg Return
Past Year
Past Year
5.5%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
63%
Neutral
37%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Materials
Real Estate
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Healthcare Plans
Health Information Services
Medical Devices
Medical Distribution
Medical Instruments & Supplies
Pharmaceutical Retailers
Materials
Specialty Chemicals
Real Estate
Diversified REIT
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $16 |
54%
upside
| 3 | +29% |
0
%
| 27 Feb ‘26 6 days ago |
|
|
|
Outperform
Maintained
| $326 |
16%
upside
| 3 | +5.4% |
0
%
| 18 Feb ‘26 15 days ago |
|
|
|
Outperform
Initiated
| $48 |
12%
upside
| 1 | +5.8% |
0
%
| 12 Jan ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $927 |
5%
downside
| 1 | +16% |
0
%
| 6 Nov ‘25 3 months ago |
|
|
|
Outperform
Upgraded
| $199 |
11%
upside
| 2 | +7.1% |
0
%
| 6 Nov ‘25 3 months ago |
|
|
|
Outperform
Upgraded
| $258 |
45%
upside
| 3 | -18% |
0
%
| 29 Oct ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $224 |
103%
upside
| 3 | -16% |
0
%
| 2 Sep ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| $194 |
7%
downside
| 3 | +3.6% |
0
%
| 25 Aug ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $27 | – | 2 | – |
–
| 20 Aug ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $203 |
9%
downside
| 2 | +27% |
0
%
| 13 Aug ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $7 |
192%
upside
| 2 | -48% |
0
%
| 12 Aug ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $490 |
5%
upside
| 2 | – |
–
| 23 Jul ‘25 7 months ago |
|